1Chen ME, Johnston DA,Tang K, et al. Detailed mapping of prostate carcinoma loci: biopsy strategy implications[J]. Cancer, 2000, 89(8): 1800-1809.
2Vis AN, Boerma MO, Ciatto S, et al. Detection of prostate cancer:a comparative study of the diagnostic efficacy of sextant transrectal versus sextant transperineal biopsy[J]. Urology, 2000, 56(4): 617-621.
3Ficarra V, Novella G, Novara G, et al. The potential impact of prostatevolume in the planning of optimal number of cores in the systematic transperineal prostate biopsy[J]. Eur Urol, 2005, 48(6): 932-937.
6Raja J, Ramachandran N, Munneke, et al. Current status of transrectal ultrasound-guided prostate biopsy in the diagnosis of prostate cancer[J]. Clin Radiol, 2006, 61(2): 142-153.
6TAKENAKA A, HARA R, ISHIMURA T, et al. A prospective randomized comparison of diagnostic efficacy between transperineal and transreetal 12-core prostate biopsy [J]. Prostate Cancer Prostatic Dis, 2008, 11(2) : 134-138.
7NOVARA G, BOSCOLO-BERTO R, LAMON C, et al. Detection rate and factors predictive the presence of prostate in patients undergoing ultrasonography-guided transperineal saturation biopsies of the prostate[J]. BJU Int, 2010, 105(9): 1242-1246.
8Egawa S,Ohori M,Uchida T,et al. Nodular hyperplasia in the peripheral zone of the prostate gland. Br Jurol, 1994,74:520-521.
9Spitz J, Enzmann T, Muller W, et al. Estimation of total PSA with a super- sensitive PSA-assay during neo-adjuvant-chemotherapy of prostate cancer before radical resection of prostate. Anticancer Res, 1999, 19: 2637- 2640.
10Ohori M, Kattan MW, Utsunomiya T, et al. Do Impalpable stage Tie pros- tate cancers visible on ultrasound differ form those not visible. Jurol, 2003.169,964-968.
